Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome.
暂无分享,去创建一个
N. Schmitz | A. Ho | C. Pott | P. Dreger | M. Kneba | M. Hensel | M. Rieger | B. Seyfarth